Package 70518-2455-2

{"route": ["ORAL"], "spl_id": "4a291680-febd-5eac-e063-6394a90ab919", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "unii": ["X4HES1O11F"], "rxcui": ["197311"], "spl_set_id": ["6d0e492e-5359-49e8-812d-8c8e2e5d42f8"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["REMEDYREPACK INC."]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE, PLASTIC (70518-2455-2)", "package_ndc": "70518-2455-2", "marketing_start_date": "20201023"}, {"sample": false, "description": "21 TABLET in 1 BOTTLE, PLASTIC (70518-2455-3)", "package_ndc": "70518-2455-3", "marketing_start_date": "20210825"}], "brand_name": "Acyclovir", "product_id": "70518-2455_4a291680-febd-5eac-e063-6394a90ab919", "dosage_form": "TABLET", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "70518-2455", "generic_name": "Acyclovir", "labeler_name": "REMEDYREPACK INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "400 mg/1"}], "application_number": "ANDA203834", "marketing_category": "ANDA", "marketing_start_date": "20191125", "listing_expiration_date": "20271231"}